Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-285638
Filing Date
2022-11-15
Accepted
2022-11-15 15:01:54
Documents
7
Period of Report
2022-11-15

Document Format Files

Seq Description Document Type Size
1 6-K d422559d6k.htm 6-K 10427
2 EX-99.1 d422559dex991.htm EX-99.1 22900
3 EX-99.2 d422559dex992.htm EX-99.2 28141
4 GRAPHIC g422559g1115164749576.jpg GRAPHIC 2601
5 GRAPHIC g422559g1115164841043.jpg GRAPHIC 2601
6 GRAPHIC g422559g1115182653227.jpg GRAPHIC 1087
7 GRAPHIC g422559g1115183519194.jpg GRAPHIC 1087
  Complete submission text file 0001193125-22-285638.txt   73409
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 221390791
SIC: 2834 Pharmaceutical Preparations